Inspire Trust Co. N.A. Purchases 251 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Inspire Trust Co. N.A. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,102 shares of the healthcare conglomerate’s stock after acquiring an additional 251 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Inspire Trust Co. N.A.’s holdings, making the stock its 16th biggest holding. Inspire Trust Co. N.A.’s holdings in UnitedHealth Group were worth $5,322,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Coronation Fund Managers Ltd. lifted its position in UnitedHealth Group by 1.4% in the second quarter. Coronation Fund Managers Ltd. now owns 94,397 shares of the healthcare conglomerate’s stock valued at $48,073,000 after purchasing an additional 1,261 shares during the last quarter. Pure Financial Advisors LLC boosted its position in UnitedHealth Group by 1.7% during the 2nd quarter. Pure Financial Advisors LLC now owns 4,469 shares of the healthcare conglomerate’s stock valued at $2,276,000 after buying an additional 73 shares during the period. TruNorth Capital Management LLC increased its position in shares of UnitedHealth Group by 262.5% in the second quarter. TruNorth Capital Management LLC now owns 116 shares of the healthcare conglomerate’s stock valued at $59,000 after acquiring an additional 84 shares during the period. Old Port Advisors grew its stake in shares of UnitedHealth Group by 4.5% in the second quarter. Old Port Advisors now owns 943 shares of the healthcare conglomerate’s stock worth $480,000 after purchasing an additional 41 shares during the last quarter. Finally, Rappaport Reiches Capital Management LLC raised its position in UnitedHealth Group by 2.8% during the 2nd quarter. Rappaport Reiches Capital Management LLC now owns 1,081 shares of the healthcare conglomerate’s stock valued at $551,000 after purchasing an additional 29 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $515.73 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $474.62 billion, a price-to-earnings ratio of 33.60, a price-to-earnings-growth ratio of 1.57 and a beta of 0.58. The business has a 50-day moving average price of $583.29 and a 200-day moving average price of $559.30.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the company posted $6.56 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Ratings Changes

A number of brokerages recently commented on UNH. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. KeyCorp started coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Finally, UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $626.84.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.